The making of a disease: Female sexual dysfunction

Ray Moynihan*

*Corresponding author for this work

Research output: Contribution to journalArticleProfessional

309 Citations (Scopus)

Abstract

The corporate sponsored creation of a disease is not a new phenomenon,1 but the making of female sexual dysfunction is the freshest, clearest example we have. A cohort of researchers with close ties to drug companies are working with colleagues in the pharmaceutical industry to develop and define a new category of human illness at meetings heavily sponsored by companies racing to develop new drugs. The most recent gathering, featured Pfizer as chief sponsor and Pfizer-friendly researchers as chief speakers. The venue? The Pfizer Foundation Hall for Humanism in Medicine at New York University Medical School.
Original languageEnglish
Pages (from-to)45-47
Number of pages3
JournalBritish Medical Journal
Volume326
Issue number7379
DOIs
Publication statusPublished - 4 Jan 2003
Externally publishedYes

Fingerprint

Dive into the research topics of 'The making of a disease: Female sexual dysfunction'. Together they form a unique fingerprint.

Cite this